<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=9185424728244267&amp;ev=PageView&amp;noscript=1">

Pintuition® Marker · for radiology

Navigation
starts with you.

The radiologist’s placement is where every accurate excision begins.

The simple Pintuition Marker placement workflow

7 and 12 cm
Needle length
Two lengths available to match tumour depth and patient anatomy.
Rice-grain sized
Marker size
Small enough to place through a standard applicator with minimal tissue disruption.
Titanium
Implant material
Nickel-free and biocompatible — no risk of nickel allergy.
Long-term placement
FDA-clearedMDR CE marked
Place at any time — same day, or weeks to months ahead of surgery.

The Pintuition Marker

The power of a permanent magnet.

A rice-grain sized, non-radioactive marker in nickel-free biocompatible titanium. Its field never decays since it’s a permanent magnet, making the marker detectable from any direction, even in fluid, challenging lighting or near electrocautery. FDA-cleared for long-term placement, so the marker can be placed on the day of surgery or weeks to months in advance, allowing flexible scheduling.MDR CE marked for long-term placement, so the marker can be placed on the day of surgery or weeks to months in advance, allowing flexible scheduling.

The permanent magnet and its surrounding magnetic field lines — a constant field detectable from any direction.
360° signal performance

360° signal performance

Consistent signal detection regardless of marker orientation, providing reliable localization and accurate distance feedback.

No signal loss

No signal loss

A permanent magnet always has a field, even in fluids, challenging lighting or near electrocautery.

Robust marker

Robust marker

A high-grade biocompatible titanium housing ensures durability and reliable performance without nickel allergy concerns, whether placed on the day of surgery or months in advance.

Minimal discomfort

Minimal discomfort

Intuitive, accurate devices that help clinicians deliver optimal care.

Non-radioactive

Non-radioactive

No nuclear medicine department or radiation-safety administrative burden.

Preloaded 14G Pintuition needle with the magnetic marker glowing at the tip.
  • Marker5 × 1.6 mm, in a biocompatible titanium housing
  • Needle14G, available in 7 and 12 cm lengths, with an ultrasound-enhanced tip
  • IndicationAny soft-tissue localization including breast and lymph nodes; long-term implantation indicated for surgical removal
  • VisibilityCompatible with all major imaging workflows, including ultrasound, X-ray (including stereotactic and contrast-enhanced mammography (CEM)), and CT

Optimize your radiology workflow.

Sirius Pintuition offers precise localization of non-palpable lesions, which can significantly improve surgical planning and outcomes.

Diagnosis & treatment plan
Time
Surgical Treatment

Advantages

Key advantages of using Pintuition as a Surgical Marker

Greater scheduling flexibility

Place the marker at any time — same day, or weeks to months before surgery.

Easy deployment

A 14G applicator in 7 and 12 cm lengths, preloaded with the marker and an ultrasound-enhanced tip.

Perfect visibility on imaging modalities

Compatible with all major imaging workflows, including ultrasound, X-ray (including stereotactic and contrast-enhanced mammography (CEM)), and CT.

Cost effective

Reduce delays, streamline workflows, and make better use of radiology and OR resources.

On imaging

Pintuition Marker Visualization Across Imaging Modalities

UltrasoundUltrasound — the Pintuition needle and marker clearly labelled.
X-ray (mammography)X-ray mammography — Pintuition marker localised on the mammogram.
X-ray (specimen)X-ray specimen radiograph — Pintuition marker confirmed within the excised specimen.
Contrast enhancement mammography (CEM)Contrast-enhanced mammography (CEM) post-deployment of the Pintuition marker — low-energy and recombined views showing the marker in situ.
Axillary Lymph nodeAxillary lymph node — Pintuition marker visible within the excised node.

Clinical evidence

Proven at placement and at surgery.

Drawn from peer-reviewed, real-world experience across European, UK and US centers.

2.8mmMedian marker-to-target distance at placementPisarcik 2025 · n=67
100%Lesion localization & marker retrieval, 200 consecutive casesCeccato 2025
80,000+Patients treated globallySirius Medical
97.4%Clear margins (invasive carcinoma), equivalent to wireStengs 2023 · n=85

Trust and Embrace Surgical Marker Navigation

Radiologists and surgeons on Pintuition.

ETZ Hospital
Dr. Floriaan Dijkman
Radiologist · ETZ Hospital, Netherlands
“We can now schedule up to a few weeks before the surgery, instead of placing the Pintuition marker on the day of the surgery or the day prior to surgery. So it gives more flexibility.”
UZ Leuven
Dr. Barbara Geeroms
Radiologist · UZ Leuven, Belgium
“The image visibility with ultrasound with the Pintuition Marker is very good. When you move the transducer a little, the marker is easily visible again because of its radiopacity. It’s also easily visible on the confirmation mammography.”
Rode Kruis Ziekenhuis
Dr. Suzanna van Veen
Radiologist · Rode Kruis Hospital, Netherlands
“The Pintuition marker placement can be planned one or two weeks in advance of surgery, which is not only convenient for the radiology department, but also for the patient.”
Valley Hospital Medical Center
Matthew Miller, MD
Breast Surgeon · Valley Hospital Medical Center
“What really blew me away was the directionality. I had never worked with another localizer that could give me a three-dimensional direction to target.”
Augusta Health
Shannon Tierney, MD, FACS
Breast Surgeon · Augusta Health Breast Surgery
“Because it’s extremely reliable and the targeting is so excellent, I know that my dissection is going in the correct direction from the get-go. I can choose to place my incision wherever I think it’s going to be the most cosmetic choice for the patient, and I don’t have to worry about compromising the oncologic resection.”
Northwell Health
Renee Aboushi, MD
Breast Surgeon · Northwell Health
“What surprised me about using the Pintuition device was how easy it was to train surgical trainees on the localization tool. The Pintuition system fit into my surgical workflow seamlessly.”
Medical City Weatherford
Amelia Gunter, MD
Breast Surgeon · Medical City Weatherford
“We can place our incision where we want it and still find the marker and the tumor quickly.”
ETZ Hospital
Dr. Floriaan Dijkman
Radiologist · ETZ Hospital, Netherlands
“We can now schedule up to a few weeks before the surgery, instead of placing the Pintuition marker on the day of the surgery or the day prior to surgery. So it gives more flexibility.”
UZ Leuven
Dr. Barbara Geeroms
Radiologist · UZ Leuven, Belgium
“The image visibility with ultrasound with the Pintuition Marker is very good. When you move the transducer a little, the marker is easily visible again because of its radiopacity. It’s also easily visible on the confirmation mammography.”
Rode Kruis Ziekenhuis
Dr. Suzanna van Veen
Radiologist · Rode Kruis Hospital, Netherlands
“The Pintuition marker placement can be planned one or two weeks in advance of surgery, which is not only convenient for the radiology department, but also for the patient.”
Maasziekenhuis Pantein
Dr. Janneke Berlage
Maasziekenhuis Pantein
“I only see advantages in it, you can operate more accurately which leads to better cosmetic outcomes.”
Dijklander Ziekenhuis
Dr. Louise de Widt
Dijklander Ziekenhuis
“With this new technique, the shortest path to the anomaly can be selected, and less tissue needs to be removed. This better preserves the breast, which is crucial for reconstruction.”
Portsmouth Hospitals University NHS Trust
Miss Tamara Kiernan
Portsmouth Hospitals University NHS Trust
“It simply works every time.”
Rode Kruis Ziekenhuis
Dr. Gisela Moormann
Rode Kruis Ziekenhuis
“I think it’s a really great development. Of course for the patients, but the technical advantage for surgeons is also enormous.”

Get started with your Pintuition® trial

Try the Pintuition Marker in the clinic today and give your patients a better standard of breast cancer care with intuitive placement and minimal discomfort.

  • With long-term placement indication the marker can be placed weeks or months ahead of surgery for complete scheduling flexibility.
  • Compatible with all major imaging workflows, including ultrasound, X-ray and CT.
  • No nuclear medicine department or radiation-safety administrative burden.
  • 100% lesion localization & marker retrieval across 200 consecutive cases (Ceccato 2025).
  • Approved for use in soft tissues, including the breast and axilla.
Ordered through our partner Mammotome in the US & Canada.
80,000+Patients treated globally
Sirius Medical

Arrange your Pintuition trial

FAQs

Frequently asked questions

What is the chance of Pintuition Marker migration?

Smaller, radioactive iodine seeds have been shown not to migrate [1] and a previous version of the Sirius Pintuition device was associated with negligible migration (all <1mm) after an implantation duration of median 18 (13-29) days, N=5 [2]”. [1] Alderliesten T, Loo CE, Pengel KE, Rutgers EJT, Gilhuijs KGA, Vrancken Peeters MTFDJTFD. Radioactive seed localization of breast lesions: an adequate localization method without seed migration. Breast J [Internet]. United States; 2011; 17: 594– 601. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21906208 [2] Schermers B, van der Hage JA, Loo CE, Vrancken Peeters MTFD, Winter-Warnars HAO, van Duijnhoven F, et al. Feasibility of magnetic marker localisation for nonpalpable breast cancer. Breast [Internet]. Elsevier Ltd; 2017; 33: 50–56. Available from: http://dx.doi.org/10.1016/j.breast.2017.03.003

Is the Pintuition Marker compatible with MRI imaging?

The Pintuition Marker is labelled as MR conditionally safe; this means patients with a Pintuition Marker in situ can safely undergo an MR scan (under certain conditions), but this will lead to image artefacts around the marker. The Pintuition Needle is not safe for use during MRI, so it is not safe to implant the marker under MR guidance. Please refer to the Instructions for Use for specific information.

Is the Pintuition Marker approved for use during neoadjuvant therapy and how does this impact MRI response evaluation?

There is no contra-indication for the use of Pintuition during neoadjuvant therapy. The device is approved for use both in the primary lesion and in lymph nodes. However, the clinicians should be aware of the imaging artefact on MRI. In a worstcase test setting the maximum artefact extended approximately 6cm from the seed. The minimum artefact extends 2,5 cm from the seed. The artefact in your center will depend on your own imaging settings and system. If you are interested we can provide a detailed test report.

Is the Pintuition Marker approved for use in the Axilla or Inguinal lymph nodes?

Yes, in the EU and the US, the Pintuition Marker is approved for use in any soft tissue lesion for long term placement. Please refer to your local Instructions for Use document for the complete indications for use.

How long in advance can the seed be placed?

The Pintuition Marker has long-term indication status in the use of soft tissue lesions in both the US and EU. This means you can safely place it days, weeks or months ahead of surgery without issue.

Is the Sirius Pintuition Marker visible on my imaging system?

The Sirius Pintuition Marker is compatible with all major imaging workflows, including ultrasound, X-ray (including stereotactic and contrast-enhanced mammography (CEM)), and CT.

View all FAQs →